Literature DB >> 9176700

Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo.

K A Pape1, E R Kearney, A Khoruts, A Mondino, R Merica, Z M Chen, E Ingulli, J White, J G Johnson, M K Jenkins.   

Abstract

Adoptive transfer of TCR-transgenic T cells uniformly expressing an identifiable TCR of known peptide/MHC specificity can be used to monitor the in vivo behavior of antigen-specific T cells. We have used this system to show that naive T cells are initially activated within the T-cell zones of secondary lymphoid tissue to proliferate in a B7-dependent manner. If adjuvants or inflammatory cytokines are present during this period, enhanced numbers of T cells accumulate, migrate into B-cell-rich follicles, and acquire the capacity to produce IFN-gamma and help B cells produce IgG2a. If inflammation is absent, most of the initially activated antigen-specific T cells disappear without entering the follicles, and the survivors are poor producers of IL-2 and IFN-gamma. Our results indicate that inflammatory mediators play a key role in regulating the anatomic location, clonal expansion, survival and lymphokine production potential of antigen-stimulated T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176700     DOI: 10.1111/j.1600-065x.1997.tb00959.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  46 in total

Review 1.  Th1/Th2 balance in atopy.

Authors:  T Biedermann; M Röcken
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Clonal expansion of antigen-specific CD4 T cells following infection with Salmonella typhimurium is similar in susceptible (Itys) and resistant (Ityr) BALB/c mice.

Authors:  Z M Chen; M K Jenkins
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  Comparative T cell receptor repertoire selection by antigen after adoptive transfer: a glimpse at an antigen-specific preimmune repertoire.

Authors:  V Attuil; P Bucher; M Rossi; M Mutin; J L Maryanski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  In situ characterization of genetically targeted (green fluorescent) single cells and their microenvironment in an adoptive host.

Authors:  F Leithäuser; Z Trobonjaca; J Reimann; P Möller
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen.

Authors:  Claudia Rollenhagen; Meike Sörensen; Konstantin Rizos; Robert Hurvitz; Dirk Bumann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

6.  Systemic protein delivery by muscle-gene transfer is limited by a local immune response.

Authors:  Lixin Wang; Eric Dobrzynski; Alexander Schlachterman; Ou Cao; Roland W Herzog
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

7.  Naive T-cell receptor transgenic T cells help memory B cells produce antibody.

Authors:  Darragh Duffy; Chun-Ping Yang; Andrew Heath; Paul Garside; Eric B Bell
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

8.  In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Authors:  Donata Medaglini; Annalisa Ciabattini; Anna Maria Cuppone; Caterina Costa; Susanna Ricci; Massimo Costalonga; Gianni Pozzi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

9.  Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.

Authors:  Daniela I M Loeffler; Christoph U Schoen; Werner Goebel; Sabine Pilgrim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 10.  T cell receptor antagonism in vivo, at last.

Authors:  S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.